Adhesion molecules as a prognostic marker of liver cirrhosis

Scandinavian Journal of Gastroenterology

Volumn 40, Issue 2, 2005, Pages 217-224

  Girón González, José A ^a   Martinez Sierra C ^a   Rodriguez Ramos, C ^a   Rendon P ^a   Macias M A ^a   Fernandez Gutierrez C ^a   Diaz F ^a   Martin Herrera L ^a  

^a HOSPITAL UNIVERSITARIO PUERTA DEL MAR   (Spain)

Author keywords

Intercellular cell adhesion molecule 1; Liver cirrhosis; Pro inflammatory cytokines; Tumor necrosis factor receptors; Vascular cell adhesion molecule

Indexed keywords

ALDOSTERONE; CD14 ANTIGEN; CELL ADHESION MOLECULE; CYTOKINE; INTERCELLULAR ADHESION MOLECULE 1; NORADRENALIN; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; VASCULAR CELL ADHESION MOLECULE 1; VASOPRESSIN;

ADULT; ALDOSTERONE BLOOD LEVEL; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; FEMALE; HEMODYNAMICS; HUMAN; INFECTION; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; NORADRENALIN BLOOD LEVEL; PLASMA RENIN ACTIVITY; PORTAL HYPERTENSION; PRIORITY JOURNAL; VASOPRESSIN BLOOD LEVEL;

AGED; ANTIGENS, CD14; BIOLOGICAL MARKERS; CELL ADHESION MOLECULES; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECEPTORS, TUMOR NECROSIS FACTOR; VASCULAR CELL ADHESION MOLECULE-1;

EID: 13244278017     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365520510011470     Document Type: Article

References (40)

1. Navasa M, Rimola A, Rodés J. Bacterial infections in liver disease. Semin Liver Dis 1997;17:323-33.
2. Tilg H, Wilmer A, Vogel W, Herold M, Nolchen B, Judmaier G, et al. Serum levels of cytokines in chronic liver diseases. Gastroenterology 1992;103:264-74.
3. Albillos A, de la Hera A, González M, Moya JL, Calleja JL, Monserrat J, et al. Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement. Hepatology 2003;37:208-17.
4. Borrelli E, Roux-Lombard P, Grau GE, Ricou B, Dayer J, Suter PM. Plasma concentrations of cytokines, their soluble receptors, and antioxidant vitamins can predict the development of multiple organ failure in patients at risk. Crit Care Med 1996;24:392-7.
5. Zeni F, Tardy B, Vindimian M, Comtet C, Page Y, Cusey I, et al. High levels of tumor necrosis factor-a and interleukin-6 in the ascitic fluid of cirrhotic patients with spontaneous bacterial peritonitis. Clin Infect Dis 1993;17:218-23.
6. Propst T, Propst A, Herold M, Schauer G, Judmaier G, Braunsteiner H, et al. Spontaneous bacterial peritonitis is associated with high levels of interleukin-6 and its secondary mediators in ascitic fluid. Eur J Clin Invest 1993;23:832-6.
7. Rodriguez-Ramos C, Galán F, Díaz F, Elvira J, Martín-Herrera L, Girón-González JA. Expression of proinflammatory cytokines and their inhibitors during the course of spontaneous bacterial peritonitis. Dig Dis Sci 2001;46:1668-76.
8. Girón-González JA, Martínez-Sierra C, Rodríguez-Ramos C, Macias MA, Rendón P, Fernández C, et al. Implication of inflammation-related cytokines in the natural history of liver cirrhosis. Liver Int 2004;24:437-45.
9. Carlos TM, Harlan JM. Leukocyte-endothelial adhesion molecules. Blood 1994;84:2068-101.
10. Rothlein R, Mainolfi EA, Czajkowski M, Marlin SD. A form of circulating ICAM-1 in human serum. J Immunol 1991;147:3788-93.
11. Pigott R, Dillon LP, Hemingway IH, Gearing AJH. Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatant of cytokine activated cultured endothelial cells. Biochem Biophys Res Commun 1992;187:584-9.
12. Genesca J, Gonzalez A, Segura R, Catalan R, Marti R, Varela E, et al. Interleukin-6, nitric oxide, and the clinical and hemodynamic alterations of patients with liver cirrosis. Am J Gastroenterol 1999;94:169-77.
13. Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH, Rodés J. Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 1988;8:1151-7.
14. Porcel A, Díaz F, Rendón P, Macías M, Martín-Herrera L, Girón-González JA. Dilutional hyponatremia in patients with cirrhosis and ascites. Arch Intern Med 2002;162:323-8.
15. Girón-González JA, Rodríguez-Ramos C, Elvira J, Galán F, Fernández-Gutiérrez del Álamo C, Díaz F, et al. Serial analysis of serum and ascitic fluid levels of soluble adhesion molecules and chemokines in patients with spontaneous bacterial peritonitis. Clin Exp Immunol 2001;123:56-61.
16. Ginés A, Escorsell A, Ginés P, Salo J, Jimenez W, Inglada L, et al. Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites. Gastroenterology 1993;105:229-36.
17. Arroyo V, Ginés P, Gerbes AL, Dudley FJ, Gentilini P, Laffi G, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. Hepatology 1996;23:164-76.
18. Rimola A, García-Tsao G, Navasa M, Piddock LJ, Planas R, Bernard B, et al. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. J Hepatol 2000;32:142-53.
19. de Franchis R. Updating consensus in portal hypertension: report of the Baveno III consensus workshop on definitions, methodology and therapeutics strategies in portal hypertension. J Hepatol 2000;33:846-52.
20. Moore KP, Wong F, Gines P, Bernardi M, Ochs A, Salerno F, et al. The management of ascites in cirrhosis: report on the Conference of the International Ascites Club. Hepatology 2003;38:258-66.
21. Solis-Herruzo JA, Gómez-Gamarra A, Castellano G, Muñoz-Yagüe MT. Metabolic clearance rate of arginine vasopressin in patients with cirrhosis. Hepatology 1992;16:974-9.
22. Elizalde JI, Moitinho E, García-Pagán JC, Cirera I, Escorsell A, Bandi JC, et al. Effects of increasing blood hemoglobin levels on systemic hemodynamics of acutely anemic cirrhotic patients. J Hepatol 1998;29:789-95.
23. Hadengue A, Gadano A, Moreau R, Giostra E, Durand F, Valla D, et al. Beneficial effects of the 2-day administration of terlipressin in patients with cirrhosis and hepatorenal syndrome. J Hepatol 1998;29:565-70.
24. Andus T, Gross V, Holstege A, Weber M, Ott M, Gerok W, et al. Evidence for the production of high amounts of interleukin-6 in the peritoneal cavity of patients with ascites. J Hepatol 1992;15:378-81.
25. Tartaglia LA, Goeddel DV. Two TNF receptors. Immunol Today 1992;13:151-3.
26. Díez-Ruiz A, Tiltz GP, Zangerle R, Baier-Bitterlich G, Wachter H, Fuchs D. Soluble receptors for tumor necrosis factor in clinical laboratory diagnostics. Eur J Haematol 1995;54:1-8.
27. Naveau S, Abella A, Raynard B, Balian A, Giraud V, Montembault S, et al. Tumor necrosis factor soluble receptor p55 and lipid peroxidation in patients with acute alcoholic hepatitis. Am J Gastroenterol 2001;96:3361-7.
28. Deswal A, Petersen NJ, Feldman AM, Young JB, White BG, Mann DL. Cytokines and cytokine receptors in advanced heart failure. Circulation 2001;103:2055-9.
29. Spitzer JA. Cytokine stimulation of nitric oxide formation and differential regulation in hepatocytes and nonparenchymal cells of endotoxemic rats. Hepatology 1994;19:217-28.
30. Bomzon A, Blendis LM. The nitric oxide hypothesis and the hyperdynamic circulation in cirrhosis. Hepatology 1994;20:1343-50.
31. García-Tsao G, Angulo P, Garcia JC, Groszman RJ, Cadelina GW. The diagnostic and predictive value of ascites nitric oxide levels in patients with spontaneous bacterial peritonitis. Hepatology 1998;28:17-21.
32. Llach J, Ginés P, Arroyo V, Rimola A, Tito L, Badalamenti S, et al. Prognostic value of arterial pressure, endogenous vasoactive systems and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites. Gastroenterology 1988;94:482-7.
33. Abad-Lacruz A, Cabré E, González-Huix F, Fernandez-Banares F, Esteve M, Planas R, et al. Routine test of renal function, alcoholism, and nutrition improve the prognosis accuracy of Child-Pugh score in nonbleeding advanced cirrhosis. Am J Gastroenterol 1993;88:382-7.
34. Zeni F, Tardy B, Vindimian M, Comtet C, Page Y, Cusey I, et al. High levels of tumor necrosis factor-α and interleukin-6 in the ascitic fluid of cirrhotic patients with spontaneous bacterial peritonitis. Clin Infect Dis 1993;17:218-23.
35. Navasa M, Follo A, Filella X, Jimenez W, Francitorra A, Planas R, et al. Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: relationship with the development of renal impairment and mortality. Hepatology 1998;27:1227-32.
36. Bone RC. Immunologic dissonance: a continuing evolution in our understanding of the systemic inflammatory response syndrome and multiple organ dysfunction syndrome. Ann Intern Med 1996;125:680-7.
37. Casey LC, Balk RA, Bone RC. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med 1993;119:771-8.
38. Dinarello CA. Proinflammatory cytokines. Chest 2000;118:503-8.
39. Beutler B, Grau GE. Tumor necrosis factor in the pathogenesis of infectious diseases. Crit Care Med 1993;21: S423-35.
40. Barton RW, Rothlein R, Ksiazek J, Kennedy C. The effect of intercellular adhesion molecules-1 on phorbol-ester-induced rabbit lung inflammation. J Immunol 1989;143:1278-82.